A phase I, open-label, cohort study of two doses of coxsackievirus A21 given intratumorally in stage IV melanoma.
D. Shafren
Employment or Leadership Position - Viralytics ; Viralytics (I)
Consultant or Advisory Role - Viralytics
Stock Ownership - Viralytics
Research Funding - Viralytics
Other Remuneration - Viralytics
B. M. Smithers
No relevant relationships to disclose
M. Formby
No relevant relationships to disclose